bioAffinity Technologies, Inc. Earnings Per Share (Basic)
bioAffinity Technologies, Inc. (BIAF) reported Earnings Per Share (Basic) of -$0.64 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-07
- bioAffinity Technologies, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.64.
- bioAffinity Technologies, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.81.
- bioAffinity Technologies, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.70.
- bioAffinity Technologies, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$4.74.
- bioAffinity Technologies, Inc. earnings per share, basic for fiscal 2025 was -$8.66.
- bioAffinity Technologies, Inc. earnings per share, basic for fiscal 2024 was -$22.50.
- bioAffinity Technologies, Inc. earnings per share, basic for fiscal 2023 was -$0.91.
- bioAffinity Technologies, Inc. earnings per share, basic for fiscal 2022 was -$1.81.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.64 10-Q · filed 2026-08-07 | -$1.44 10-Q · filed 2026-08-07 | -$2.14 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$3.98 derived: net income ÷ weighted average shares · filed 2026-08-07 | ||||
| 2026-03-31 | -$0.81 10-Q · filed 2026-05-11 | -$1.51 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$3.53 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$5.86 derived: net income ÷ weighted average shares · filed 2026-08-07 | ||||
| 2025-12-31 | -$0.70 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$2.96 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$5.80 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$8.66 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | -$4.74 10-Q · filed 2025-11-14 | -$9.76 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$7.55 10-Q · filed 2025-11-14 | -$20.31 derived: net income ÷ weighted average shares · filed 2026-08-07 | ||||
| 2025-06-30 | -$5.07 10-Q · filed 2026-08-07 | -$0.17 10-Q · filed 2025-08-14 | -$10.01 10-Q · filed 2026-08-07 | -$0.20 10-Q · filed 2025-08-14 | -$15.83 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$20.79 derived: net income ÷ weighted average shares · filed 2026-08-07 | ||
| 2025-03-31 | -$4.80 10-Q · filed 2026-05-11 | -$0.16 10-Q · filed 2025-05-15 | -$10.87 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$15.80 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$3.03 derived: net income ÷ weighted average shares · filed 2026-05-11 | |||
| 2024-12-31 | -$6.01 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$10.96 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$1.73 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$22.50 10-K · filed 2026-03-16 | -$0.75 10-K · filed 2025-03-31 | |||
| 2024-09-30 | -$4.84 10-Q · filed 2025-11-14 | -$0.16 10-Q · filed 2024-11-14 | -$0.70 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$16.22 10-Q · filed 2025-11-14 | -$0.54 10-Q · filed 2024-11-14 | -$1.09 derived: net income ÷ weighted average shares · filed 2025-11-14 | ||
| 2024-06-30 | -$0.19 10-Q · filed 2025-08-14 | -$0.38 10-Q · filed 2025-08-14 | -$0.63 derived: net income ÷ weighted average shares · filed 2025-08-14 | -$0.89 derived: net income ÷ weighted average shares · filed 2025-08-14 | ||||
| 2024-03-31 | -$0.20 10-Q · filed 2025-05-15 | -$0.45 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$0.71 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$0.92 derived: net income ÷ weighted average shares · filed 2025-05-15 | ||||
| 2023-12-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.52 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.72 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.91 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$0.26 10-Q · filed 2024-11-14 | -$0.47 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.65 10-Q · filed 2024-11-14 | -$0.85 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||||
| 2023-06-30 | -$0.20 10-Q · filed 2024-08-14 | -$0.38 10-Q · filed 2024-08-14 | -$0.59 derived: net income ÷ weighted average shares · filed 2024-08-14 | -$1.33 derived: net income ÷ weighted average shares · filed 2024-08-14 | ||||
| 2023-03-31 | -$0.18 10-Q · filed 2024-05-15 | -$0.38 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$1.16 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$1.38 derived: net income ÷ weighted average shares · filed 2024-05-15 | ||||
| 2022-12-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$1.05 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$1.31 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$1.81 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | -$1.17 10-Q · filed 2023-11-14 | -$1.45 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$2.03 10-Q · filed 2023-11-14 | -$3.94 derived: net income ÷ weighted average shares · filed 2023-11-14 | ||||
| 2022-06-30 | -$0.03 10-Q · filed 2023-08-14 | -$0.58 10-Q · filed 2023-08-14 | -$2.66 derived: net income ÷ weighted average shares · filed 2023-08-14 | -$3.23 derived: net income ÷ weighted average shares · filed 2023-08-14 | ||||
| 2022-03-31 | -$0.55 10-Q · filed 2023-05-15 | -$2.63 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$3.20 derived: net income ÷ weighted average shares · filed 2023-05-15 | |||||
| 2021-12-31 | -$2.08 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$2.65 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$2.36 10-K · filed 2023-03-31 | |||||
| 2021-09-30 | -$0.57 10-Q · filed 2022-11-14 | -$0.28 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |